Fig. 5From: LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verificationThe prognostic value of PROS1 in LGG. A Forest plots showing the HRs related to PROS1 expression in pan-cancer. B–H Kaplan–Meier curves for patients stratified by different expression levels of PROS1 in TCGA (B, C), CGGA, GEPIA database (E), OncoLnc (F), PrognoScan database (G, H). I–J 1-, 2- and 3 year overall survival ROC curves based on risk score in TCGA (I)and CGGA cohorts (J)Back to article page